Текст книги "COVID-19/SARS-CoV-2"

291. Abdulkhaleq LA, Assi MA, Abdullah R, et al. The crucial roles of inflammatory mediators in inflammation: a review. Vet World. 2018;11 (5):627—635.

292. Robb CT, Goepp M, Rossi AG, et al. Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19. Br J Pharmacol. 2020;177 (21):4899—4920.

293. Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, et al. SARSCoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62—75.

294. Brinkman JE, Sharma S. Physiology, Respiratory Drive. StatPearls. Treasure Island, Florida, USA): StatPearls Publishing LLC.; 2020.

295. Marshall JM. Chemoreceptors and cardiovascular control in acute and chronic systemic hypoxia. Braz J Med Biol Res. 1998;31 (7):863—888.

296. Qian J. -Y, Wang B, Liu B, -C: acute Kidney Injury in the 2019 Novel Coronavirus Disease. Kidney Dis. 2020;6 (5):318—323.

297. CDC. 2019 Novel Coronavirus, Wuhan, China. CDC. [Cited 2021 March 19]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/about/index.html.

298. LabCorp. Accelerated Emergency Use Authorization (EUA) Summary COVID-19 RT-PCR Test (Laboratory Corporation of America); [Cited 2021 March 19]. Available from: https://www.fda.gov/media/136151/download.

299. Tang YW, Schmitz JE, Persing DH, et al. Laboratory Diagnosis of COVID-19: current Issues and Challenges. J Clin Microbiol. 2020;58 (6):e00512—e00520.

300. Johns Hopkins Bloomberg School of Public Health. Center for Health Security. Serology testing for COVID-19. [Cited 2021 March 19]. Available from: https://www.centerforhealthsecurity.org/resources/COVID-19/COVID-19-fact-sheets/200228-Serology-testing-COVID.pdf.

301. WHO. Criteria for COVID-19 vaccine prioritization. [Cited 2021 March 19]. Available from: https://www.who.int/who-documentsdetail/criteria-for-covid-19-vaccine-prioritization.

302. Fadem B. BRS Behavioral Science. 8th ed. Philadelphia, USA: Wolters Kluwer; 2020.

303. Akunyili A, Gonzalez-Mayo A, Tyler-Lloyd M, et al. (editors). USMLE Step1 Lecture Notes 2019: behavioral Science and Social Sciences. New York: Kaplan Medical, 2019. p.255.

304. USMLE Step 3 Lecture Notes 2019—2020: internal Medicine, Psychiatry, Ethics. Lieber JJ, Noto FP, Castro MA, et al., editors. New York: Kaplan Medical. 2019. p.484.

305. Le T, Bhushan V, Sochat M, et al. First Aid for the USMLE Step 1. 13th ed. New York: McGraw-Hill Education; 2020. p.265.

306. J E Gómez-Mesa, Stephania Galindo-Coral, Maria Claudia Montes, Andrés J Muñoz Martin. Thrombosis and Coagulopathy in COVID-19. Curr Probl Cardiol. 2021 Mar;46 (3):100742. doi: 10.1016/j. cpcardiol.2020.100742. Epub 2020 Nov 2. PMID: 33243440 PMCID: PMC7605852.

307. R Almamlouk, T Kashour, S Obeidat et al. COVID-19-Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review. Clin Microbiol Infect. 2022 Aug;28 (8):1066—1075. doi: 10.1016/j.cmi.2022.03.021. Epub 2022 Mar 23.

308. Ya Gao, Ming Liu, Yamin Chen, et al. Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis. First published: 20 July 2020 https://doi.org/10.1002/jmv.26311.

309. R Di Girolamo, A Khalil, S Alameddine et al. Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2021 Nov;3 (6):100468. doi: 10.1016/j. ajogmf.2021.100468. Epub 2021 Aug 21.

310. O Dadras, A M Afsahi, Z Pashaei et al. The relationship between COVID-19 viral load and disease severity: A systematic review. Immun Inflamm Dis. 2022 Mar;10 (3):e580. doi: 10.1002/iid3.580. Epub 2021 Dec 13.

311. Zeng-Hong Wu, Yun Tang, Qing Cheng. Diabetes increases the mortality of patients with COVID-19: a meta-analysis. Acta Diabetol. 2021 Feb;58 (2):139—144. doi: 10.1007/s00592-020-01546-0. Epub 2020 Jun 24.

312. S Misra, K Kolappa, M Prasad et al. Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis. Neurology. 2021 Dec 7;97 (23):e2269-e2281. doi: 10.1212/WNL.0000000000012930. Epub 2021 Oct 11.

313. P Zarifkar, A Kamath, C Robinson et al. Clinical Characteristics and Outcomes in Patients with COVID-19 and Cancer: a Systematic Review and Meta-analysis. Clin Oncol (R Coll Radiol). 2021 Mar;33 (3):e180-e191. doi: 10.1016/j.clon.2020.11.006. Epub 2020 Nov 19.

314. Yanfei He, Jie Wang, Junlin Ren et al. Effect of COVID-19 on Male Reproductive System – A Systematic Review. Front Endocrinol (Lausanne). 2021 May 27;12:677701. doi: 10.3389/fendo.2021.677701. eCollection 2021.

315. S Peiris, H Mesa, A Aysola et al. Pathological findings in organs and tissues of patients with COVID-19: A systematic review. PLoS One. 2021 Apr 28;16 (4):e0250708. doi: 10.1371/journal. pone.0250708. eCollection 2021.

316. A Maiese, A C Manetti, C Bosetti et al. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19. Brain Pathol. 2021 Nov;31 (6):e13013. doi: 10.1111/bpa.13013. Epub 2021 Aug 13.

317. C Axfors, P Janiaud, A M Schmitt et al. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials. BMC Infect Dis. 2021 Nov 20;21 (1):1170. doi: 10.1186/s12879-021-06829-7.

318. R M Kariyawasam, D A Julien, D C Jelinski et al. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021). Antimicrob Resist Infect Control. 2022 Mar 7;11 (1):45. doi: 10.1186/s13756-022-01085-z.

319. G S Manzano, C R S McEntire, M Martinez-Lage, et al. Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis. Neurol Neuroimmunol Neuroinflamm. 2021 Aug 27;8 (6):e1080. doi: 10.1212/NXI.0000000000001080. Print 2021 Nov.

320. Jeremy W Jacobs, Garrett S Booth. COVID-19 and Immune-Mediated RBC Destruction. Am J Clin Pathol. 2022 Jun 7;157 (6):844—851. doi: 10.1093/ajcp/aqab210.

321. A Pormohammad, S Ghorbani, A Khatami et al. Comparison of influenza type A and B with COVID-19: A global systematic review and meta-analysis on clinical, laboratory and radiographic findings. Rev Med Virol. 2021 May;31 (3):e2179. doi: 10.1002/rmv.2179. Epub 2020 Oct 9.

322. S Syahrul, H A Maliga, M Ilmawan et al. Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis – a systematic review and meta-analysis. F1000Res. 2021 Jan 19;10:34. doi: 10.12688/f1000research.42308.1. eCollection 2021.

323. A Maiese, P Frati, F Del Duca et al. Myocardial Pathology in COVID-19-Associated Cardiac Injury: A Systematic Review. Diagnostics (Basel). 2021 Sep 8;11 (9):1647. doi: 10.3390/diagnostics11091647.

324. A Maiese, A C Manetti, R La Russa et al. Autopsy findings in COVID-19-related deaths: a literature review. Forensic Sci Med Pathol. 2021 Jun;17 (2):279—296. doi: 10.1007/s12024-020-00310-8. Epub 2020 Oct 7.

325. J Christensen, K O’Callaghan, H Sinclair et al. Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review. Intern Med J. 2022 Apr;52 (4):522—529. doi: 10.1111/imj.15432.

326. S Satturwar, M Fowkes, C Farver et al. Postmortem Findings Associated With SARS-CoV-2: Systematic Review and Meta-analysis. Am J Surg Pathol. 2021 May 1;45 (5):587—603. doi: 10.1097/PAS.0000000000001650.

327. J Aragoneses, A Suárez, J Algar et al. Oral Manifestations of COVID-19: Updated Systematic Review With Meta-Analysis. Front Med (Lausanne). 2021 Aug 25;8:726753. doi: 10.3389/fmed.2021.726753. eCollection 2021.

328. R G Menezes, T Rizwan, S Saad Ali et al. Postmortem findings in COVID-19 fatalities: A systematic review of current evidence. Leg Med (Tokyo). 2022 Feb;54:102001. doi: 10.1016/j. legalmed.2021.102001. Epub 2021 Dec 7.

329. J R Hannah, S Sasha Ali, D Nagra et al. Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection. Clin Exp Rheumatol. 2022 Feb;40 (2):329—338. doi: 10.55563/clinexprheumatol/mkfmxt. Epub 2022 Feb 25.

330. T J Cooper, B L Woodward, S Alom, A Harky. Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review. HIV Med. 2020 Oct;21 (9):567—577. doi: 10.1111/hiv.12911. Epub 2020 Jul 15.

331. M Creta, C Sagnelli, G Celentano et al. SARS-CoV-2 infection affects the lower urinary tract and male genital system: A systematic review. J Med Virol. 2021 May;93 (5):3133—3142. doi: 10.1002/jmv.26883. Epub 2021 Mar 1.

332. Y Du, Y Lv, W Zha et al. Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis. Metabolism 2021 Apr;117:154373. doi: 10.1016/j.metabol.2020.154373. Epub 2020 Sep 16.

333. A Ciapponi, A Bardach, D Comandé et al. COVID-19 and pregnancy: An umbrella review of clinical presentation, vertical transmission, and maternal and perinatal outcomes. PLoS One. 2021 Jun 29;16 (6):e0253974. doi: 10.1371/journal. pone.0253974. eCollection 2021.

334. G Lippi, B M. Henry, E J. Favaloro. Mean Platelet Volume Predicts Severe COVID-19 Illness. Semin Thromb Hemost 2021; 47 (04): 456—459 DOI: 10.1055/s-0041-1727283. Letter to the Editor.

335. S Tomerak, S Khan, M Almasri et al. Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review. Scand J Immunol. 2021 Nov;94 (5):e13097. doi: 10.1111/sji.13097. Epub 2021 Sep 27.

336. A Fitero, S G Bungau, D Mirela Tit et al. Comorbidities, Associated Diseases, and Risk Assessment in COVID-19-A Systematic Review. Int J Clin Pract. 2022 Oct 31;2022:1571826. doi: 10.1155/2022/1571826. eCollection 2022.

337. S. R. Bornstein, R. Dalan, D. Hopkins, et al, «Endocrine and metabolic link to coronavirus infection,» Nature Reviews Endocrinology, vol. 16, pp. 297—298, 2020.

338. J. Seiglie, J. Platt, S. J. Cromer et al., «Diabetes as a risk factor for poor early outcomes in patients hospitalized with COVID-19,» Diabetes Care, vol. 43, pp. 2938—2944, 2020.

339. A. Mansour, S. M. Sajjadi-Jazi, A. Kasaeian et al., «Clinical characteristics and outcomes of diabetics hospitalized for COVID-19 infection: a single-centered, retrospective, observational study,» EXCLI journal, vol. 19, p. 1533, 2020.

340. J. de la Cuesta-Zuluaga, N. T. Mueller, V. Corrales-Agudelo et al., «Metformin is associated with higher relative abundance of mucin-degrading akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut,» Diabetes Care, vol. 40, pp. 54—62, 2017.

341. A. B. Crouse, T. Grimes, P. Li, et al, «Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes,» Frontiers in Endocrinology, vol. 11, 2021.

342. M. Gawałko, A. Kapłon-Cieślicka, M. Hohl, et al, «COVID-19 associated atrial fibrillation: incidence, putative mechanisms and potential clinical implications,» IJC Heart & Vasculature, vol. 30, Article ID 100631, 2020.

343. M. Nishiga, D. W. Wang, Y. Han, et al, «COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives,» Nature Reviews Cardiology, vol. 17, pp. 543—558, 2020.

344. U. Zahid, P. Ramachandran, S. Spitalewitz et al., «Acute kidney injury in COVID-19 patients: an inner city hospital experience and policy implications,» American Journal of Nephrology, vol. 51, pp. 786—796, 2020.

345. B. M. Henry and G. Lippi, «Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection,» International Urology and Nephrology, vol. 52, pp. 1193—1194, 2020.

346. J. M. Yang, H. Y. Koh, S. Y. Moon et al., «Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study,» Journal of Allergy and Clinical Immunology, vol. 146, 2020.

347. J. M. Leung, C. X. Yang, A. Tam et al., «ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19,» European Respiratory Journal, vol. 55, 2020.

348. S. Villapol, «Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome,» Translational Research, vol. 226, pp. 57—69, 2020.

349. J. G. Hashash, S. Jabak, F. F. Francis, and M. Regueiro, «Should we Be screening for SARS-CoV-2 in IBD patients before initiation of biologic therapy?» Inflammatory Bowel Diseases, vol. 27, pp. 291—294, 2020.

350. S. Khanna and C. S. Kraft, «The interplay of SARS-CoV-2 and Clostridioides difficile infection,» Future Microbiology, vol. 16, pp. 439—443, 2021.

351. J. Sun, A. Aghemo, A. Forner e L. Valenti, «COVID-19 e malattie del fegato», Liver International, vol. 40, pp. 1278—1281, 2020.

352. X. Jin, J.-S. Lian, J.-H. Hu et al., «Caratteristiche epidemiologiche, cliniche e virologiche di 74 casi di malattia infetta da coronavirus 2019 (COVID-19) con sintomi gastrointestinali», Gut, vol. 69, pp. 1002—1009, 2020.

353. S. Yaghi, K. Ishida, J. Torres et al., «SARS-CoV-2 and stroke in a New York healthcare system,» Stroke, vol. 51, pp. 2002—2011, 2020.

354. M. B. Malas, I. N. Naazie, N. Elsayed, A. Mathlouthi, R. Marmor, and B. Clary, «Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis,» EClinicalMedicine, vol. 29, Article ID 100639, 2020.

355. T. Baldini, G. M. Asioli, M. Romoli et al., «Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis,» European Journal of Neurology, vol. 28, pp. 3478—3490, 2021.

356. F. Caso, L. Costa, P. Ruscitti et al., «Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?» Autoimmunity Reviews, vol. 19, Article ID 102524, 2020.

357. S. Pascolini, A. Vannini, G. Deleonardi et al., «COVID-19 and immunological dysregulation: can autoantibodies be useful?» Clinical and Translational Science, vol. 14, pp. 502—508, 2021.

358. P. Caron, «Thyroiditis and SARS-CoV-2 pandemic: a review,» Endocrine, vol. 72, pp. 326—331, 2021.

359. J. G. Hashash, S. Jabak, F. F. Francis, and M. Regueiro, «Should we Be screening for SARS-CoV-2 in IBD patients before initiation of biologic therapy?» Inflammatory Bowel Diseases, vol. 27, pp. 291—294, 2020.

360. D. T. Rubin, M. T. Abreu, V. Rai et al., «Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting,» Gastroenterology, vol. 159, 2020.

361. D. T. Rubin, J. D. Feuerstein, A. Y. Wang, and R. D. Cohen, «AGA clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary,» Gastroenterology, vol. 159, pp. 350—357, 2020.

362. F. Castillo Álvarez, M. Á. López Pérez, and M. E. Marzo Sola, «Risk of SARS-CoV-2 infection and clinical outcomes in multiple sclerosis patients in La Rioja (Spain): riesgo de infección por SARS-CoV-2 y resultados clínicos en pacientes con esclerosis múltiple en la Rioja (España),» Medicina Clínica, vol. 155, pp. 362—363, 2020.

363. C. Galeotti and J. Bayry, «Autoimmune and inflammatory diseases following COVID-19,» Nature Reviews Rheumatology, vol. 16, pp. 413—414, 2020.

364. C. Galván Casas, A. Català, G. Carretero Hernández et al., «Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases,» British Journal of Dermatology, vol. 183, pp. 71—77, 2020.

365. A. V. Marzano, G. Genovese, G. Fabbrocini et al., «Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients,» Journal of the American Academy of Dermatology, vol. 83, pp. 280—285, 2020.

366. A. M. Jimenez-Cebrian, A. Castro-Mendez, B. García-Podadera et al., «Clinical manifestations of COVID-19 in the feet: a review of reviews,» Journal of Clinical Medicine, vol. 10, 2021.

367. H Hammoud, A Bendari, T Bendari, I Bougmiza. Histopathological Findings in COVID-19 Cases: A Systematic Review. Cureus. 2022 Jun 1;14 (6):e25573. doi: 10.7759/cureus.25573. eCollection 2022 Jun.

368. WHO – WHO COVID-19 Case definition. https://www.who.int/publications/i/item/WHO-2019-nCoV-Surveillance_Case_Definition-2020.1 Дата посещения 18.01.23.

369. Lomoro P, Verde F, Zerboni F, et al, 2020. COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review. Eur J Radiol Open 7: 100231.

370. Fiala MJ, 2020. Ultrasound in COVID-19: a timeline of ultrasound findings in relation to CT. Clin Radiol S0009—9260: 30143—30144.

371. Yasukawa K, Minami T. Point-of-care lung ultrasound findings in patients with novel coronavirus disease (COVID-19) pneumonia. Am J Trop Med Hyg, 2020. doi: 10.4269/ajtmh.20—0280.

372. M F H Mohamed, S Al-Shokri, Z Yousaf et al. Frequency of Abnormalities Detected by Point-of-Care Lung Ultrasound in Symptomatic COVID-19 Patients: Systematic Review and Meta-Analysis. Am J Trop Med Hyg. 2020 Aug;103 (2):815—821. doi: 10.4269/ajtmh.20—0371. Epub 2020 Jun 2.

373. Certificazione verde COVID-19 EU digital COVID certificate – Esenzione dalla vaccinazione anti COVID-19 https://www.dgc.gov.it/web/esenzione.html;Дата посещения 19.01.2023.

374. Circ Min Salute 0035309—04/08/2021-DGPRE-DGPRE-P.

375. M E Flacco, C A Martellucci, G Soldato, et al. COVID-19 Vaccination Did Not Increase the Risk of Potentially Related Serious Adverse Events: 18-Month Cohort Study in an Italian Province. Vaccines 2023, 11 (1), 31; https://doi.org/10.3390/vaccines11010031. Received: 18 November 2022 / Revised: 17 December 2022 / Accepted: 20 December 2022 / Published: 23 December 2022.

376. Menendez JA, Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19, in Aging (Albany NY), vol. 12, n. 10, maggio 2020, pp. 8760—8765, DOI:10.18632/aging.103347.

377. Lauc G, Markotić A, Gornik I, Primorac D, Fighting COVID-19 with water, in J Glob Health, vol. 10, n. 1, giugno 2020, p. 010344, DOI:10.7189/jogh.10.010344.

378. Wang J, Tang K, Feng K, Lv W. High temperature and high humidity reduce the transmission of COVID-19. SSRN Electron J. In press. doi:10.2139/ssrn.3551767.

379. Araujo MB, Naimi B. Spread of SARS-CoV-2 Coronavirus likely to be constrained by climate. medRxiv, 2020.

380. Ogen Y, Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality, in Sci. Total Environ., vol. 726, luglio 2020, p. 138605, DOI:10.1016/j.scitotenv.2020.138605.

381. Wu X, Nethery RC, Sabath BM, et al. Exposure to air pollution and COVID-19 mortality in the United States: A nationwide cross-sectional study, in medRxiv, aprile 2020, DOI:10.1101/2020.04.05.20054502.

382. Martelletti L, Martelletti P, Air Pollution and the Novel Covid-19 Disease: a Putative Disease Risk Factor, in SN Compr Clin Med, aprile 2020, pp. 1—5, DOI:10.1007/s42399-020-00274-4.

383. Frontera A, Martin C, Vlachos K, Sgubin G. Regional air pollution persistence links to COVID-19 infection zoning, in J. Infect., aprile 2020, DOI:10.1016/j. jinf.2020.03.045.

384. Cui Y, Zhang ZF, Froines J, et al. Air pollution and case fatality of SARS in the People’s Republic of China: an ecologic study, in Environ Health, vol. 2, n. 1, novembre 2003, p. 15, DOI:10.1186/1476—069X-2-15.

385. Setti L, Passarini F, De Gennaro G, et al. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough, in Int J Environ Res Public Health, vol. 17, n. 8, aprile 2020, DOI:10.3390/ijerph17082932.

386. Q Zhang, P Bastard, Z Liu, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19, in Science, 2020, pp. eabd4570, DOI:10.1126/science. abd4570, ISSN 0036—8075 (WC · ACNP).

387. P Bastard, L B. Rosen, Q Zhang, et al. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19, in Science, 2020, pp. eabd4585, DOI:10.1126/science. abd4585, ISSN 0036—8075 (WC · ACNP).

388. Novelli A, Andreani M, Biancolella M, et al. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients, in HLA, agosto 2020, DOI:10.1111/tan.14047.

389. L Zou, F Ruan, M Huang, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients, in New England Journal of Medicine, vol. 382, n. 12, 2020, pp. 1177—1179, DOI:10.1056/NEJMc2001737.

390. M Merad e J C. Martin. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages, in Nature Reviews Immunology, vol. 20, n. 6, 2020, pp. 355—362, DOI:10.1038/s41577-020-0331-4, ISSN 1474—1733 (WC · ACNP).

391. S Tian, Y Xiong, H Liu, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies, in Modern Pathology, vol. 33, n. 6, 2020, pp. 1007—1014, DOI:10.1038/s41379-020-0536-x.

392. SA SeyedAlinaghi, A Karimi, A Barzegary et al. COVID-19 mortality in patients with immunodeficiency and its predictors: a systematic review. Eur J Med Res. 2022 Oct 8;27 (1):195. doi: 10.1186/s40001-022-00824-7.

393. Anju Khairwa, Kana Ram Jat. Autopsy findings of COVID-19 in children: a systematic review and meta-analysis. Forensic Sci Med Pathol. 2022 Dec;18 (4):516—529. doi: 10.1007/s12024-022-00502-4. Epub 2022 Sep 1.

394. J C Sánchez-García, N P Carrascosa Moreno, M I Tovar-Gálvez et al. COVID-19 in Pregnant Women, Maternal-Fetal Involvement, and Vertical Mother-to-Child Transmission: A Systematic ReviewBiomedicines. 2022 Oct 13;10 (10):2554. doi: 10.3390/biomedicines10102554.

395. Diriba, K.; Awulachew, E.; Getu, E. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: A systematic review and meta-analysis. Eur. J. Med. Res. 2020, 25, 39. Available online: https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-020-00439-w (accessed on 29 August 2022).

396. Schwartz, D.A.; Hyg, M. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Arch. Pathol. Lab. Med. 2020, 144, 799—805. Available online: https://meridian.allenpress.com/aplm/article/144/7/799/441923/An-Analysis-of-38-Pregnant-Women-With-COVID-19 (accessed on 29 August 2022).

397. Aghaamoo, S.; Ghods, K.; Rahmanian, M. Pregnant women with COVID-19: The placental involvement and consequences. J. Mol. Histol. 2021, 52, 427—435. Available online: https://link.springer.com/article/10.1007/s10735-021-09970-4 (accessed on 29 August 2022).

398. Wang, C.L.; Liu, Y.Y.; Wu, C.H.; et al. Impact of COVID-19 on Pregnancy. Int. J. Med. Sci. 2021, 18, 763. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797535/ (accessed on 29 August 2022).

399. Ghema, K.; Lehlimi, M.; Toumi, H.; et al. Outcomes of newborns to mothers with COVID-19. Infect. Dis. Now 2021, 51, 435—439.

400. Saroyo, Y.B.; Rumondang, A.; Febriana, I.S.; et al. Remdesivir Treatment for COVID 19 in Pregnant Patients with Moderate to Severe Symptoms: Serial Case Report. Infect. Dis. Rep. 2021, 13, 437—443.

401. Wiese, M.D.; Berry, M.J.; Hissaria, P.; et al. COVID-19: Can we treat the mother without harming her baby? J. Dev. Orig. Health Dis. 2022, 13, 9—19.

402. Crovetto, F.; Crispi, F.; Llurba, E. et al. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Infection on Pregnancy Outcomes: A Population-based Study. Clin. Infect. Dis. 2021, 73, 1768—1775.

403. Jamieson, D.J.; Rasmussen, S.A. An update on COVID-19 and pregnancy. Am. J. Obstet. Gynecol. 2022, 226, 177—186.

404. Khedmat, L.; Mohaghegh, P.; Veysizadeh, M.; Hosseinkhani, A.; Fayazi, S.; Mirzadeh, M. Pregnant women and infants against the infection risk of COVID-19: A review of prenatal and postnatal symptoms, clinical diagnosis, adverse maternal and neonatal outcomes, and available treatments. Arch. Gynecol. Obstet. 2021, 306, 323—335.

405. Dhir, S.K.; Kumar, J.; Meena, J.; Kumar, P. Clinical Features and Outcome of SARS-CoV-2 Infection in Neonates: A Systematic Review. J. Trop. Pediatr. 2021, 67, fmaa059.

406. M González Cañete, I Mujica Valenzuela, P Carvajal Garcés et al. Saliva sample for the massive screening of SARS-CoV-2 infection: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021 May;131 (5):540—548. doi: 10.1016/j. oooo.2021.01.028. Epub 2021 Feb 1.

407. P Liana, I A Liberty, K Murti et al. A systematic review on neutrophil extracellular traps and its prognostication role in COVID-19 patients. Immunol Res. 2022 Aug;70 (4):449—460. doi: 10.1007/s12026-022-09293-w. Epub 2022 May 23.

408. W Ibrahim. Neurological manifestations in coronavirus disease 2019 (COVID-19) patients: a systematic review of literature. CNS Spectr. 2022 Apr;27 (2):145—156. doi: 10.1017/S1092852920001935. Epub 2020 Oct 21.

409. S Alhumaid, A A Rabaan, K Dhama et al. Solid Organ Rejection following SARS-CoV-2 Vaccination or COVID-19 Infection: A Systematic Review and Meta-Analysis. Vaccines (Basel). 2022 Aug 10;10 (8):1289. doi: 10.3390/vaccines10081289.

410. S Houben, B Bonnechère. The Impact of COVID-19 Infection on Cognitive Function and the Implication for Rehabilitation: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2022, 19 (13), 7748; https://doi.org/10.3390/ijerph19137748. Received: 31 May 2022 / Revised: 20 June 2022 / Accepted: 23 June 2022 / Published: 24 June 2022.

411. Z Asif, Z Chen, S Stranges et al. Dynamics of SARS-CoV-2 spreading under the influence of environmental factors and strategies to tackle the pandemic: A systematic review. Sustain Cities Soc. 2022 Jun;81:103840. doi: 10.1016/j.scs.2022.103840. Epub 2022 Mar 16.

412. A Roy, N Verma, S Singh et al. Immune-mediated liver injury following COVID-19 vaccination: A systematic review. Hepatol Commun. 2022 Sep;6 (9):2513—2522. doi: 10.1002/hep4.1979. Epub 2022 May 4.

413. C Fernández-de-Las-Peñas, K I Notarte, P Juneire Peligro et al. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature. Viruses. 2022 Nov 25;14 (12):2629. doi: 10.3390/v14122629.

414. J Leal, B Farkas, L Mastikhina et al. Risk of transmission of respiratory viruses during aerosol-generating medical procedures (AGMPs) revisited in the COVID-19 pandemic: a systematic review. Antimicrob Resist Infect Control. 2022 Aug 11;11 (1):102. doi: 10.1186/s13756-022-01133-8.

415. S Manoharan, L Y Ying. Does baricitinib reduce mortality and disease progression in SARS-CoV-2 virus infected patients? A systematic review and meta analysis. Respir Med. 2022 Oct;202:106986. doi: 10.1016/j. rmed.2022.106986. Epub 2022 Sep 16.

416. I D Rosero, J Barreto, C Cardona, L T Ordoñez-Mora. Physical, Functional, Psychological, and Social Effects of a Physical Activity Program in Adults and Older Adults During and/or After Hospitalization for COVID-19: A Systematic Review. Risk Manag Healthc Policy. 2022 Dec 22;15:2399—2412. doi: 10.2147/RMHP. S386708. eCollection 2022.

417. K I Notarte, M H Santos de Oliveira, P J Peligro et al. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J Clin Med. 2022 Dec 9;11 (24):7314. doi: 10.3390/jcm11247314.

418. S Giryes, N L Bragazzi, C Bridgewood et al. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells. Semin Immunopathol. 2022 May;44 (3):375—390. doi: 10.1007/s00281-022-00928-6. Epub 2022 Apr 12.

419. G Cosentino, M Todisco, N Hota et al. Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: A critical systematic review. Eur J Neurol. 2021 Nov;28 (11):3856—3865. doi: 10.1111/ene.15045. Epub 2021 Aug 17.

420. G M ElGohary, S Hashmi, J Styczynski et al. The Risk and Prognosis of COVID-19 Infection in Cancer Patients: A Systematic Review and Meta-Analysis. Hematol Oncol Stem Cell Ther. 2022 Jun 1;15 (2):45—53. doi: 10.1016/j. hemonc.2020.07.005.

421. M A Waheed, K Rashid, T Rajab et al. Role of anticoagulation in lowering the mortality in hospitalized covid-19 patients: Meta-analysis of available literature. Saudi Med J. 2022 Jun;43 (6):541—550. doi: 10.15537/smj.2022.43.6.20220046.

422. E C Rosca, C Heneghan, E A Spencer et al. Transmission of SARS-CoV-2 associated with aircraft travel: a systematic reviewJ Travel Med. 2021 Oct 11;28 (7):taab133. doi: 10.1093/jtm/taab133.

423. S Mohammadi, M Gouravani, M A Salehi et al. Olfactory system measurements in COVID-19: a systematic review and meta-analysis. Neuroradiology. 2023 Jan;65 (1):25—39. doi: 10.1007/s00234-022-03014-8. Epub 2022 Jul 18.

424. H Wang, L Luo, We Lv et al. Comparison of chest CT features between progressive and nonprogressive patients with COVID-19 pneumonia: A meta-analysis. Medicine (Baltimore). 2022 Sep 30;101 (39):e30744. doi: 10.1097/MD.0000000000030744.

425. N Thakur, S Das, S Kumar et al. Tracing the origin of Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A systematic review and narrative synthesis. J Med Virol. 2022 Dec;94 (12):5766—5779. doi: 10.1002/jmv.28060. Epub 2022 Sep 7.

426. A Lewis, J Frontera, D G Placantonakis et al. Cerebrospinal fluid from COVID-19 patients with olfactory/gustatory dysfunction: A review. Clin Neurol Neurosurg. 2021 Aug;207:106760. doi: 10.1016/j.clineuro.2021.106760. Epub 2021 Jun 12.

427. O Dadras, S ASeyed Alinaghi, A Karimi et al. Effects of COVID-19 prevention procedures on other common infections: a systematic review. Eur J Med Res. 2021 Jul 3;26 (1):67. doi: 10.1186/s40001-021-00539-1.

428. W Yang, D Zhang, Z Li, K Zhang. Predictors of poor serologic response to COVID-19 vaccine in patients with cancer: a systematic review and meta-analysis. Eur J Cancer. 2022 Sep;172:41—50. doi: 10.1016/j. ejca.2022.05.031. Epub 2022 Jun 2.